Diving into Analyst Ratings: An In-Depth Exploration The analysis of recent analyst actions sheds light on the perception of Quest Diagnostics by financial experts. The following summary presents ...

Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $963,529.41 today based on a ...

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.

Moreover, Quest Diagnostics has increased its quarterly dividend by 6.7%, to $0.80 per share. In terms of analyst outlook, Jefferies has maintained their Buy rating for Quest Diagnostics and ...

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $175.00.

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS ...

According to TipRanks, Sergott is an analyst with an average return ... Baird maintained a Buy rating on Quest Diagnostics (NYSE: DGX). The company has a one-year high of $178.87 and a one-year ...

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

and adjustments to ratings and price targets. Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Quest Diagnostics's ...